TIMP3 and Alzheimer disease: Treatment with NF-, AD-, and LC-sSVF led to elevated TIMP-3 levels in chondrocytes (Figure 8C) and increased TIMP-1 and TIMP-3 levels in synoviocytes (Figures 8D, F).